{
    "clinical_study": {
        "@rank": "1314", 
        "arm_group": {
            "arm_group_label": "shock wave therapy", 
            "arm_group_type": "Experimental"
        }, 
        "brief_summary": {
            "textblock": "Patients with calcinosis cutis due to connective tissue disease get a shock wave therapy.\n      The shock wave therapy will be done in 3 sessions with one week interval. The outcome\n      parameters are: change in pain, size of the calcinosis, of possible ulcers and intake of\n      painkillers.\n\n        -  Trial with medical device"
        }, 
        "brief_title": "Calcinosis Cutis: Therapeutic Effects of Extracorporeal Shock Wave Therapy (ESWT)", 
        "completion_date": {
            "#text": "August 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Calcinosis Cutis Due to Connective Tissue Disease", 
        "condition_browse": {
            "mesh_term": [
                "Calcinosis", 
                "Connective Tissue Diseases"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion criteria:\n\n          -  Age of 18\n\n          -  Calcinosis cutis due to connective tissue disease\n\n          -  information about ESWT given\n\n          -  Patient understands the study and signs the informed consent\n\n        Exclusion criteria:\n\n          -  No ESWT done\n\n          -  cuagulopathy\n\n          -  sepsis\n\n          -  pregnancy\n\n          -  pace maker\n\n          -  severe disease in the opinion of the investigator\n\n          -  cardiac risk with NYHA III-IV\n\n          -  Ehlers-Danlos-Syndrome"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "15", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "September 7, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01683500", 
            "org_study_id": "CCESWT01"
        }, 
        "intervention": {
            "arm_group_label": "shock wave therapy", 
            "description": "Three sessions with shock wave therapy, interval of one week.", 
            "intervention_name": "shock wave therapy with Modulith SLK (Storz)", 
            "intervention_type": "Device"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "September 12, 2012", 
        "location": {
            "facility": {
                "address": {
                    "city": "Zurich", 
                    "country": "Switzerland", 
                    "state": "ZH", 
                    "zip": "8091"
                }, 
                "name": "University Hospital Zurich, Division of Rheumatology"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Switzerland"
        }, 
        "number_of_arms": "1", 
        "overall_contact": {
            "email": "sandra.blumhardt@usz.ch", 
            "last_name": "Sandra Blumhardt, MD", 
            "phone": "+41 (0)44 255 11 11"
        }, 
        "overall_official": {
            "affiliation": "University Hospital Zurich, Division of Rheumatology", 
            "last_name": "Sandra Blumhardt, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Switzerland: Swissmedic", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 3", 
        "primary_completion_date": {
            "#text": "August 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "change in pain", 
            "safety_issue": "No", 
            "time_frame": "after 6 weeks"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01683500"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "University of Zurich", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "University of Zurich", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "August 2012", 
        "study_design": "Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "September 2012"
    }
}